Each year, Clarivate releases the Journal Citation Report (JCR), containing updated impact factors for peer-reviewed journals. In 2021, RSC showed great increases in impact factor across much of the portfolio, with some of the largest growth and highest impact journals shown in the graphic above. Furthermore, many of our journals now stand at their 5-year (and all-time) high!
In addition to this advance, we are also excited to announce that our new journal, RSC Medicinal Chemistry, has received its first impact factor (3.47) – a milestone that requires a certain number of articles and citations gathered over the first two or four years of its publication. You can learn more about how impact factors are calculated and the variables that determine its first issuance on the Clarivate webpage. Another of our new journals, Nanoscale Advances, showed a >20% increase over its first impact factor that was released in 2020! A full report of RSC journals’ impact is available here (Clarivate subscription required).
We are happy to share our performance in this year’s JCR, and we look forward to carrying this growth into the future.
